Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction

Felicita Andreotti, Filippo Crea, Giampaolo Niccoli, Francesca Marzo, Silvia Cecchetti, Eleonora Santucci, Domenico D'Amario, Nicola Cosentino

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

In models of acute ischaemia, erythropoietin (EPO) administration has been found to attenuate vascular injury largely through reduced apoptosis, suppressed inflammation and increased nitric oxide availability. We studied the association between circulating endogenous EPO and no-reflow in patients with first ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
Lingua originaleEnglish
pagine (da-a)1210-1219
Numero di pagine10
RivistaEuropean Journal of Clinical Investigation
Volume41
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • Aged
  • Biological Markers
  • Coronary Angiography
  • Electrocardiography
  • Erythropoietin
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction
  • No-Reflow Phenomenon
  • Regression Analysis

Fingerprint

Entra nei temi di ricerca di 'Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction'. Insieme formano una fingerprint unica.

Cita questo